REBECCA JOHNSTON: Open Payments
NPI 1558475426 · LEOMINSTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 44 payments from 18 companies in 2025. Trend: 2023 $1,119 · 2024 $738 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $213 |
| Novo Nordisk Inc | 4 | $94 |
| Lilly USA, LLC | 4 | $82 |
| PFIZER INC. | 3 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| SANOFI PASTEUR INC. | 1 | $41 |
| Exact Sciences Corporation | 2 | $38 |
| Lundbeck LLC | 2 | $32 |
| ViiV Healthcare Company | 1 | $32 |
| Astellas Pharma US Inc | 1 | $26 |
Products named: VRAYLAR, MOUNJARO, Wegovy, CAPLYTA, NURTEC ODT, BEYFORTUS, The Cologuard Plus Collection Kit, REXULTI.
Industry payments across MA — which companies pay providers there.
